WANT A PROFILE LIKE THIS?
Create my FREE Plan Or learn about other options
Jiangjiang Qin
PeerJ Editor
2,835 Points

Contributions by role

Editor 2,835

Contributions by subject area

Biochemistry
Cell Biology
Molecular Biology
Hematology
Neurology
Oncology
Pharmacology
Histology
Urology
Epidemiology
Pathology
Translational Medicine
Evidence Based Medicine
Pediatrics
Rehabilitation
Radiology and Medical Imaging
Genomics
Diabetes and Endocrinology
Internal Medicine
Nephrology
Anesthesiology and Pain Management
Cognitive Disorders
Orthopedics
Surgery and Surgical Specialties
Immunology
Respiratory Medicine
Gastroenterology and Hepatology
Global Health
Gynecology and Obstetrics
Women's Health
Microbiology
Metabolic Sciences
Obesity
Drugs and Devices
Dentistry
Veterinary Medicine
Sports Injury
Sports Medicine
Bioinformatics
Medical Genetics
Cardiology
Genetics

Jiangjiang Qin

PeerJ Editor

Summary

Dr. Jiangjiang Qin is currently a Professor of Cancer Pharmacology and Drug Discovery at the Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences and the Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital).

Dr. Qin received his B.S. degree in Pharmacy (2006) and Ph.D. in Biomedical Engineering with the highest honor (2011) from Shanghai Jiao Tong University, China, under the supervision of Professor Wei-Dong Zhang. After completion of Post-Doctoral training in cancer biology, pharmacology, and molecular therapeutics at Texas Tech University Health Sciences Center (TTUHSC) in 2014, Dr. Qin continued his research work at TTUHSC as a Research Associate and a Senior Research Associate and at the University of Houston as a Senior Research Scientist. Dr. Qin joined Zhejiang Chinese Medicinal University as a Full Professor in 2018 and then moved to IBMC in 2020.

Dr. Qin’s research mainly focuses on the discovery and development of novel, effective, and safe anticancer agents as well as demonstrating the molecular targets and mechanisms of action. He has published more than 150 research papers and reviews. He is also an Associate Editor of Frontiers in Pharmacology and Frontiers in Oncology and an Editorial Board Member of more than 10 scientific journals such as Recent Patents on Anti-Cancer Drug Discovery, Journal of Cancer Research Updates, World Journal of Traditional Chinese Medicine.

Biochemistry Cell Biology Drugs & Devices Gastroenterology & Hepatology Immunology Molecular Biology Oncology Pharmacology

Editorial Board Member

PeerJ - the Journal of Life & Environmental Sciences

Work details

Professor and Principal Investigator

Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences
September 2020
Center for Innovative Drugs and Precision Medicine
Dr. Qin has significant expertise in cancer biology, cancer pharmacology, natural product chemistry, and medicinal chemistry. His laboratory focuses to discover new cancer biomarkers and drug targets by applying innovative bioinformatics approaches, elucidate the molecular mechanisms underlying the development, progression, metastasis, and drug resistance of human cancer, especially gastric and pancreatic cancer, and develop novel, effective, and safe anticancer agents by utilizing state-of-the-art technologies.

Websites

  • Google Scholar

PeerJ Contributions

  • Edited 23

Academic Editor on

February 25, 2025
Analysis of biopsies of gastric cancer, intestinal and diffuse, and non-atrophic gastritis: an overview of loss of heterozygosity in Mexican patients
Violeta Larios-Serrato, Hilda A. Valdez-Salazar, Javier Torres, Margarita Camorlinga, Patricia Piña-Sánchez, Fernando Minauro, Martha-Eugenia Ruiz-Tachiquín
https://doi.org/10.7717/peerj.18928 PubMed 40028213
June 4, 2024
Role of the transient receptor potential melastatin 4 in inhibition effect of arsenic trioxide on the tumor biological features of colorectal cancer cell
Zhan Gao, Jing Lv, Ting-Ting Tong, Kai Zhang, Yu-Xuan Han, Yu Zhao, Mei-Mei Shen, Yang Liu, Tao Ban, Yu Sun
https://doi.org/10.7717/peerj.17559 PubMed 38854798
May 9, 2024
Regulation of cellular and molecular markers of epithelial-mesenchymal transition by Brazilin in breast cancer cells
Lorena Cayetano-Salazar, Jose A. Hernandez-Moreno, Jorge Bello-Martinez, Monserrat Olea-Flores, Eduardo Castañeda-Saucedo, Monica Ramirez, Miguel A. Mendoza-Catalán, Napoleon Navarro-Tito
https://doi.org/10.7717/peerj.17360 PubMed 38737746
April 29, 2024
Association between passing return-to-sport testing and re-injury risk in patients after anterior cruciate ligament reconstruction surgery: a systematic review and meta-analysis
Wenqi Zhou, Xihui Liu, Qiaomei Hong, Jingping Wang, Xiaobing Luo
https://doi.org/10.7717/peerj.17279 PubMed 38699196
April 5, 2024
Recombinant hirudin attenuates pulmonary hypertension and thrombosis in acute pulmonary embolism rat model
Xiang Wei, Yanfen Zou, Shunli Dong, Yi Chen, Guoping Li, Bin Wang
https://doi.org/10.7717/peerj.17039 PubMed 38590700
March 29, 2024
Expression profiles and gene set enrichment analysis of the transcriptomes from the cancer tissue, white adipose tissue and paracancer tissue with colorectal cancer
Xiufeng Zhang, Rui Zhu, Ye Jiao, Halizere Simayi, Jialing He, Zhong Shen, Houdong Wang, Jun He, Suzhan Zhang, Fei Yang
https://doi.org/10.7717/peerj.17105 PubMed 38563016
December 14, 2023
Exosomes from adipose-derived stem cells alleviate premature ovarian failure via blockage of autophagy and AMPK/mTOR pathway
Yu Ren, Jinying He, Xiao Wang, Hongyu Liang, Yuzhen Ma
https://doi.org/10.7717/peerj.16517 PubMed 38107591
December 11, 2023
The accuracy of Fiber-Optic Raman Spectroscopy in the detection and diagnosis of head and neck neoplasm in vivo: a systematic review and meta-analysis
Wen Chen, Yafei Chen, Chenzhou Wu, Xidong Zhang, Xiaofeng Huang
https://doi.org/10.7717/peerj.16536 PubMed 38099303
December 7, 2023
Foxa2 attenuates steatosis and inhibits the NF-κB/IKK signaling pathway in nonalcoholic fatty liver disease
Li Yang, Qiang Ma, Jiayu Chen, Xiangcai Kong, Xiaohui Yu, Wei Wang
https://doi.org/10.7717/peerj.16466 PubMed 38084145
December 4, 2023
The clinical value of the Duke Anesthesia Resistance Scale in predicting postoperative delirium after hip fracture surgery: a retrospective study
Yaya Wang, Yan’an Jiang, Huajun Fu, Yikang Zhao, Zhao Xu
https://doi.org/10.7717/peerj.16535 PubMed 38077438
November 30, 2023
Circular RNA hsa_circ_0051246 acts as a microRNA-375 sponge to promote the progression of gastric cancer stem cells via YAP1
Minghui Deng, Yefeng Xu, Yongwei Yao, Yiqing Wang, Qingying Yan, Miao Cheng, YunXia Liu
https://doi.org/10.7717/peerj.16523 PubMed 38505381
November 29, 2023
Niraparib restrains prostate cancer cell proliferation and metastasis and tumor growth in mice by regulating the lncRNA MEG3/miR-181-5p/GATA6 pathway
Ji Cheng, Yi Sun, Huacai Zhao, Wei Ren, Dan Gao, Zhigang Wang, Wei Lv, Qingchuan Dong
https://doi.org/10.7717/peerj.16314 PubMed 38047026
November 9, 2023
Bone marrow mesenchymal stem cell-derived exosomal microRNA regulates microglial polarization
Xianwei Huang, Xiong Liu, Jiaqi Zeng, Penghui Du, Xiaodong Huang, Jiyan Lin
https://doi.org/10.7717/peerj.16359 PubMed 38025715
November 8, 2023
BIBR1532 inhibits proliferation and enhances apoptosis in multiple myeloma cells by reducing telomerase activity
Yuefeng Zhang, Xinxin Yang, Hangqun Zhou, Guoli Yao, Li Zhou, Chunyan Qian
https://doi.org/10.7717/peerj.16404 PubMed 37953768
November 1, 2023
Progress in overactive bladder: novel avenues from psychology to clinical opinions
Zhaofeng Jin, Qiumin Zhang, Yanlan Yu, Ruilin Zhang, Guoqing Ding, Tian Li, Yuping Song
https://doi.org/10.7717/peerj.16112 PubMed 37927797
October 24, 2023
Semaphorin4A promotes lung cancer by activation of NF-κB pathway mediated by PlexinB1
Xiang Wei, Zhili Liu, Yili Shen, Hui Dong, Kai Chen, Xuefei Shi, Yi Chen, Bin Wang, Shunli Dong
https://doi.org/10.7717/peerj.16292 PubMed 37901456
October 2, 2023
The value of dual-energy computed tomography (DECT) in the diagnosis of urinary calculi: a systematic review and meta-analysis of retrospective studies
Peipei Feng, Guochao Li, Peng Liang
https://doi.org/10.7717/peerj.16076 PubMed 37810769
September 12, 2023
Risk factors for adverse pregnancy outcomes in Chinese women: a meta-analysis
Yiping Huang, Junbi Xu, Bin Peng, Weiying Zhang
https://doi.org/10.7717/peerj.15965 PubMed 37719120
August 9, 2023
Review of intervention methods for language and communication disorders in children with autism spectrum disorders
Mengmeng Cui, Qingbin Ni, Qian Wang
https://doi.org/10.7717/peerj.15735 PubMed 37576502
July 26, 2023
Effects of high-risk human papillomavirus infection on P53, pRb, and survivin in lung adenocarcinoma—a retrospective study
Wenwen Sun, Hui Yang, Lu Cao, Ruochen Wu, Baoqi Ding, Xiaocui Liu, Xinli Wang, Qiang Zhang
https://doi.org/10.7717/peerj.15570 PubMed 37520249
July 19, 2023
Recent research progress on the correlation between metabolic syndrome and Helicobacter pylori infection
Qinli Xie, Yangjun He, Danni Zhou, Yi Jiang, Ying Deng, Ruoqing Li
https://doi.org/10.7717/peerj.15755 PubMed 37483988
July 12, 2023
Combinative effects of β-elemene and propranolol on the proliferation, migration, and angiogenesis of hemangioma
Zhenyu Wang, Yinxian Chen, Lin Yang, Dunbiao Yao, Yang Shen
https://doi.org/10.7717/peerj.15643 PubMed 37456875
July 4, 2023
Functionalized nanoparticles crossing the brain–blood barrier to target glioma cells
Yongyan Wu, Yufeng Qian, Wei Peng, Xuchen Qi
https://doi.org/10.7717/peerj.15571 PubMed 37426416